Saei, A. A. Et Al. 2018. Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions. Molecular and Cellular Proteomics , vol.17, no.6 , 1144-1155.

Saei, A. A., Sabatier, P., Tokat, Ü., Chernobrovkin, A., Pirmoradian, M., & Zubarev, R. A., (2018). Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions. Molecular and Cellular Proteomics , vol.17, no.6, 1144-1155.

Saei, Amir Et Al. "Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions," Molecular and Cellular Proteomics , vol.17, no.6, 1144-1155, 2018

Saei, Amir A. Et Al. "Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions." Molecular and Cellular Proteomics , vol.17, no.6, pp.1144-1155, 2018

Saei, A. A. Et Al. (2018) . "Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions." Molecular and Cellular Proteomics , vol.17, no.6, pp.1144-1155.

@article{article, author={Amir Ata Saei Et Al. }, title={Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions}, journal={Molecular and Cellular Proteomics}, year=2018, pages={1144-1155} }